At a glance
- Originator Center for Chemistry of Drugs
- Class Antiglaucomas; Antihypertensives; Ischaemic heart disorder therapies; Oxadiazoles; Small molecules
- Mechanism of Action Alpha adrenergic receptor antagonists; Beta-adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Glaucoma; Hypertension
Most Recent Events
- 28 Aug 2007 Discontinued - Clinical-Phase-Unknown for Angina pectoris in Russia (PO)
- 28 Aug 2007 Discontinued - Clinical-Phase-Unknown for Glaucoma in Russia (Ophthalmic)
- 28 Aug 2007 Discontinued - Clinical-Phase-Unknown for Hypertension in Russia (PO)